Combination therapy with cerivastatin and gemfibrozil causing rhabdomyolysis: Is the interaction predictable? [1] (multiple letters)

American Journal of Medicine

Volumn 110, Issue 8, 2001, Pages 669-670

  Tomlinson, Brian ^a   Wei Lan, Irene ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; CYTOCHROME P450 3A; FLUINDOSTATIN; GEMFIBROZIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN;

DOSE RESPONSE; DRUG METABOLISM; HUMAN; LETTER; LIPOPHILICITY; MUSCLE CELL; MYOPATHY; PRIORITY JOURNAL; RHABDOMYOLYSIS; SKELETAL MUSCLE;

ANTILIPEMIC AGENTS; DRUG THERAPY, COMBINATION; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIDINES; RHABDOMYOLYSIS;

EID: 0035368540     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00692-1     Document Type: Letter

References (6)

1. G. Alexandridis G.A. Pappas M.S. Elisaf Rhabdomyolysis due to combination therapy with cerivastatin and gemifibrozil Am J Med 109 2000 261 262
2. J.R. Guyton C.A. Dujovne D.R. Illingworth Dual hepatic metabolism of cerivastatin– clarifications Am J Cardiol 84 1999 497
3. A. Corsini S. Bellosta R. Baetta New insights into the pharmacodynamic and pharmacokinetic properties of statins Pharmacol Ther 84 1999 413 428
4. I. Hino H. Akama T. Furua Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease Arthritis Rheum 39 1996 1259 1260
5. A. Takei S. Chiba Rhabdomyolysis associated with pravastatin treatment for major depression Psychiatry Clin Neurosci 53 1999 1083 1103
6. J. Raimondeau H. Le Marec J.C. Chevallier J.B. Bouhour Biological myolysis during combined fenofibrate-pravastatin therapy Presse Med 21 1992 663 664